| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad64522099cf7cfa83c88056594530d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2692966f2e618e16cbe978b308756bce |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
| filingDate |
2002-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f7d5090791338c2dabf267b08004c37 |
| publicationDate |
2002-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02072105-A2 |
| titleOfInvention |
Improved prostanoid therapies for the treatment of glaucoma |
| abstract |
Compositions and methods for the treatment of glaucoma and/or ocular hypertension in humans utilizing improved doses of certain prostaglandin derivatives and analogs are disclosed. |
| priorityDate |
2001-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |